Nalaganje...

Emerging Therapies in Castrate-Resistant Prostate Cancer

Prostate cancer is the most common cancer in men in the United States, and despite screening and early treatment, more than 27,000 men are predicted to die of the disease this year, almost all of whom will die of castrate-resistant, metastatic cancers that have progressed despite androgen deprivatio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Zarour, Luai, Alumkal, Joshi
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682789/
https://ncbi.nlm.nih.gov/pubmed/20425621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11934-010-0104-x
Oznake: Označite
Brez oznak, prvi označite!